US Stock MarketDetailed Quotes

SRTS Sensus Healthcare

Watchlist
  • 7.250
  • +0.150+2.11%
Close Jan 3 16:00 ET
  • 7.290
  • +0.040+0.55%
Post 18:42 ET
118.83MMarket Cap12.72P/E (TTM)

Sensus Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sensus Healthcare Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.90M
8.84M
+2.94M
Beat Est.
+51.24%
+126.76%
+49.93%
EPS
-<0.01
0.07
+0.08
Beat Est.
+88.99%
+177.78%
+807.07%
Analyst Rating
Strong Buy

Dec 31, 2024

Sensus Healthcare Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.648M--
--2024/Q4-- / 10.309M--
Nov 14, 20242024/Q38.839M / 5.895M--
Aug 8, 20242024/Q29.239M / 7.002M--
May 9, 20242024/Q110.663M / 4.325M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.648M--
--2024/Q4-- / 10.309M--
Nov 14, 20242024/Q38.839M / 5.895M--
Aug 8, 20242024/Q29.239M / 7.002M--
May 9, 20242024/Q110.663M / 4.325M--

Unlock Free Earnings Estimates

Sensus Healthcare Earnings Reports

  • Sensus Healthcare | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 13:47 ET

  • Sensus Healthcare | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 15:02 ET

  • Sensus Healthcare | 10-Q: Q1 2024 Earnings Report

    May 10, 2024 12:29 ET

  • Sensus Healthcare | 10-K: FY2023 Annual Report

    Mar 15, 2024 16:48 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data